Hypoxia-Pretreated Human MSCs Attenuate Acute Kidney Injury through Enhanced Angiogenic and Antioxidative Capacities
Hypoxia preconditioning has been confirmed as an effective strategy to enhance the therapeutic potentials of mesenchymal stem cells (MSCs), such as for myocardial ischemia. However, whether hypoxia preconditioning would produce beneficial effects on MSC-based renal repair has not been demonstrated....
Main Authors: | Zhang, Wenbo, Liu, Lirui, Huo, Yanhong, Yang, Yonghong, Wang, Yaping |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123714/ |
Similar Items
-
Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mechanism
by: Qin, Zhao-hui, et al.
Published: (2012) -
SIRT1 Inhibition Affects Angiogenic Properties of Human MSCs
by: Chiara, Botti, et al.
Published: (2014) -
Corrigendum to “SIRT1 Inhibition Affects Angiogenic Properties of Human MSCs”
by: Botti, Chiara, et al.
Published: (2015) -
3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney
by: Xu, Yong, et al.
Published: (2016) -
HIF-1A and C/EBPs transcriptionally regulate adipogenic differentiation of bone marrow-derived MSCs in hypoxia
by: Jiang, Chen, et al.
Published: (2015)